Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Association of Diabetic Ketoacidosis at Onset, Diabetes Technology Uptake, and Clinical Outcomes After 1 and 2 Years of Follow-up: A Collaborative Analysis of Pediatric Registries Involving 9,269 Children With Type 1 Diabetes From Nine Countries

K. Dovc, V. Neuman, G. Gita, V. Cherubini, GT. Alonso, M. Fritsch, C. Boettcher, C. de Beaufort, RW. Holl, M. de Bock

. 2025 ; 48 (4) : 648-654. [pub] 20250401

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009344

Grantová podpora
German Robert Koch Institute
P30-DK116073 NIH, NIDDK
P30 DK116073 NIDDK NIH HHS - United States
J3-4521 Slovenian Research Agency
82DZD14E03 German Center for Diabetes Research

OBJECTIVE: This study examined the association between diabetic ketoacidosis (DKA) at type 1 diabetes diagnosis and long-term glycemic outcomes, insulin requirements, BMI SD score (SDS), and diabetes technology uptake in youth. RESEARCH DESIGN AND METHODS: Data were from nine countries (Austria, Czechia, Germany, Italy, Luxembourg, New Zealand, Slovenia, Switzerland, and U.S. [Colorado]), including youth (0.5-15.9 years) diagnosed with type 1 diabetes in 2019-2020 and followed for 2 years thereafter. Participants were divided into three groups: no DKA, nonsevere, and severe DKA at diagnosis. HbA1c, insulin requirements, BMI SDS, and use of technology, including automated insulin delivery (AID), were assessed. RESULTS: The analysis included 9,269 individuals (54.8% males, mean age 9.0 years). DKA at diagnosis was observed in 34.2% of participants and severe DKA in 12.8%. After 1 year, adjusted mean HbA1c was higher in the severe DKA group (7.41%) compared with nonsevere DKA (7.23%, P = 0.001) and no DKA groups (7.14, P < 0.001), and this difference persisted after 2 years (7.58% vs. 7.38% [P < 0.001] and vs. 7.32% [P < 0.001]). Higher BMI SDS was observed in both DKA groups compared with no DKA. The use of AID was associated with lower HbA1c levels compared with other treatment modalities and moderated differences between DKA groups after 2 years of follow-up (P = 0.072). CONCLUSIONS: Severe and nonsevere DKA at type 1 diabetes diagnosis were both associated with persistently higher HbA1c and higher BMI SDS. AID use diminishes the association of DKA at diagnosis and higher HbA1c over time.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009344
003      
CZ-PrNML
005      
20250429134549.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.2337/dc24-2483 $2 doi
035    __
$a (PubMed)39965057
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dovc, Klemen $u Department of Endocrinology, Diabetes and Metabolism, University Children's Hospital, University Medical Centre Ljubljana, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia $1 https://orcid.org/0000000192012145
245    10
$a Association of Diabetic Ketoacidosis at Onset, Diabetes Technology Uptake, and Clinical Outcomes After 1 and 2 Years of Follow-up: A Collaborative Analysis of Pediatric Registries Involving 9,269 Children With Type 1 Diabetes From Nine Countries / $c K. Dovc, V. Neuman, G. Gita, V. Cherubini, GT. Alonso, M. Fritsch, C. Boettcher, C. de Beaufort, RW. Holl, M. de Bock
520    9_
$a OBJECTIVE: This study examined the association between diabetic ketoacidosis (DKA) at type 1 diabetes diagnosis and long-term glycemic outcomes, insulin requirements, BMI SD score (SDS), and diabetes technology uptake in youth. RESEARCH DESIGN AND METHODS: Data were from nine countries (Austria, Czechia, Germany, Italy, Luxembourg, New Zealand, Slovenia, Switzerland, and U.S. [Colorado]), including youth (0.5-15.9 years) diagnosed with type 1 diabetes in 2019-2020 and followed for 2 years thereafter. Participants were divided into three groups: no DKA, nonsevere, and severe DKA at diagnosis. HbA1c, insulin requirements, BMI SDS, and use of technology, including automated insulin delivery (AID), were assessed. RESULTS: The analysis included 9,269 individuals (54.8% males, mean age 9.0 years). DKA at diagnosis was observed in 34.2% of participants and severe DKA in 12.8%. After 1 year, adjusted mean HbA1c was higher in the severe DKA group (7.41%) compared with nonsevere DKA (7.23%, P = 0.001) and no DKA groups (7.14, P < 0.001), and this difference persisted after 2 years (7.58% vs. 7.38% [P < 0.001] and vs. 7.32% [P < 0.001]). Higher BMI SDS was observed in both DKA groups compared with no DKA. The use of AID was associated with lower HbA1c levels compared with other treatment modalities and moderated differences between DKA groups after 2 years of follow-up (P = 0.072). CONCLUSIONS: Severe and nonsevere DKA at type 1 diabetes diagnosis were both associated with persistently higher HbA1c and higher BMI SDS. AID use diminishes the association of DKA at diagnosis and higher HbA1c over time.
650    _2
$a lidé $7 D006801
650    12
$a diabetická ketoacidóza $x epidemiologie $7 D016883
650    12
$a diabetes mellitus 1. typu $x epidemiologie $x komplikace $x krev $7 D003922
650    _2
$a dítě $7 D002648
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mladiství $7 D000293
650    _2
$a předškolní dítě $7 D002675
650    _2
$a glykovaný hemoglobin $x metabolismus $7 D006442
650    _2
$a registrace $7 D012042
650    _2
$a kojenec $7 D007223
650    _2
$a inzulin $x terapeutické užití $7 D007328
650    _2
$a následné studie $7 D005500
650    _2
$a hypoglykemika $x terapeutické užití $7 D007004
650    _2
$a inzulinové infuzní systémy $7 D007332
651    _2
$a Itálie $x epidemiologie $7 D007558
651    _2
$a Nový Zéland $x epidemiologie $7 D009520
651    _2
$a Lucembursko $x epidemiologie $7 D008189
651    _2
$a Německo $x epidemiologie $7 D005858
651    _2
$a Švýcarsko $x epidemiologie $7 D013557
651    _2
$a Rakousko $x epidemiologie $7 D001317
651    _2
$a Slovinsko $x epidemiologie $7 D017524
655    _2
$a časopisecké články $7 D016428
700    1_
$a Neuman, Vit $u Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
700    1_
$a Gita, Gemulla $u Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
700    1_
$a Cherubini, Valentino $u Department of Women's and Children's Health, Salesi Hospital, Ancona, Italy
700    1_
$a Alonso, G Todd $u Barbara Davis Center, University of Colorado Anschutz Medical Campus, Aurora, CO
700    1_
$a Fritsch, Maria $u Department of Pediatrics and Adolescent Medicine, Medical University Graz, Graz, Austria
700    1_
$a Boettcher, Claudia $u Paediatric Endocrinology and Diabetology, University Children's Hospital, Julie-von-Jenner Haus, University of Bern, Bern, Switzerland
700    1_
$a de Beaufort, Carine $u Department of Pediatric Diabetes and Endocrinology, Centre Hospitalier Luxembourg, Luxembourg, Luxembourg $u Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-Belval, Luxembourg
700    1_
$a Holl, Reinhard W $u Institute of Epidemiology and Medical Biometry (ZIBMT), University of Ulm, Ulm and German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
700    1_
$a de Bock, Martin $u Department of Pediatrics, University of Otago, Christchurch, New Zealand
773    0_
$w MED00001380 $t Diabetes care $x 1935-5548 $g Roč. 48, č. 4 (2025), s. 648-654
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39965057 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134545 $b ABA008
999    __
$a ok $b bmc $g 2310990 $s 1246425
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 48 $c 4 $d 648-654 $e 20250401 $i 1935-5548 $m Diabetes care $n Diabetes Care $x MED00001380
GRA    __
$p German Robert Koch Institute
GRA    __
$a P30-DK116073 $p NIH, NIDDK
GRA    __
$a P30 DK116073 $p NIDDK NIH HHS $2 United States
GRA    __
$a J3-4521 $p Slovenian Research Agency
GRA    __
$a 82DZD14E03 $p German Center for Diabetes Research
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...